Multiple Antigenic Peptide (MAPs) Polyclonal Antibody
 
Multiple Antigenic Peptide (MAPs) Polyclonal Antibody

Polyclonal Antibody by Multiple Antigenic Peptide (MAPs)

Bio-Synthesis, Inc. offers multiple antigenic peptides (MAPs) as an another method for raising antibodies using synthetic peptides. Peptides are attached through C-terminal to a small non-immunogenic polylysine 4 or 8 branching core. Synthetic peptides build upon this core result in three dimensional molecules with highly localized peptide density, resulting molecular sizes reach 13-17 kD. MAP system is a suitable for direct antibody production without the need to couple to a carrier protein. These high molar ratio and dense packing of multiple copies of the antigenic epitope in a MAP has been shown to produce strong immunogenic response 1-4. See description tab to learn more on multiple antigenic peptide (MAPs) polyclonal antibodies.

Service Features:

  • Synthesis up to 10 residues
  • Immunization of 2 rabbits
  • ELISA testing on all bleeds
  • 100-150 ml of crude serum
  • 10-12 weeks delivery
  • QC peptide by HPLC and mass spectrometry
  • 5 mgs MAP delivered to customer

BSI supplies a Polyclonal Antibody Information Sheet with each inquiry to assist in meeting customer specifications.

Select your desired custom multiple antigenic peptide (MAPs) polyclonal antibody services using Bio-Synthesis' all inclusive production packages that are scientifically proven, using species-specific schedules. Should you not find a package that suits your needs, you have the option to develop a customized host species and immunization schedule to meet your protein detection needs.

Request a quote or contact us for your multiple antigenic peptide (MAPs) polyclonal antibody packages.
Economy Class MAP Antibody (Rabbit)
Package: ES-MAP-RA070 (56 Days Immunization Protocol) Time Frame and delivery 56-70 ays
Peptide Synthesis > 70% (10 a.a 10 mg) ~8 mls of control serum
KLH/BSA conjugation via Cysteine added on C- or N-term of peptide ~100 ml collection serum
2 rabbits, 2 control bleeds, 8 immunizations (4/animal), 4 collection bleeds (2/animal) 5 mg of MAP
ELISA titer assay of collection bleed MS, HPLC of peptide, ELISA reports
  See immunization and delivery schedule.

We offer one MAP polyclonal antibody service package. User-designed production protocols are also available and can be modified from existing an package.

Serum Production Specification:
  • Immunization schedule listed below are approximate (± 2 days).
  • Two New Zealand white rabbits will be used for immunization
  • Total material required for injection for the program below is 2 mg conjugated peptide/rabbit.
  • Total amount of serum expected from a rabbit on the program below is approximately ~50-75 ml/rabbit.
  • Immunogen is emulsified in Freund's Complete Adjuvant (FCA) for initial injections.
  • Freund's Incomplete Adjuvant (FIA) is used for all subsequent injections (boosts).

Continuation of project past our standard immunization schedule is offered on a month to month basis. The standard extension protocol includes two boosters, one serum collection, and maintenance for one month. Terminal bleeds may be obtained at any time yielding approximately ~50 ml/rabbit of additional serum taken upon customer request.



Program Development of Rabbit Polyclonal Antibody: 56-70 Days

Procedure Protocol Days* Description
Phase I - Antigen design, synthesis and preparation
Antigen Preparation ~ 5 - 10 days Peptide synthesis and purification (if required) and antigen conjugation
Phase II - Immunization Schedule
Control sera collection
Initial Inoculation
Day 0
Two NZQ female rabbits and Control serum (~5 ml serum/host)
Primary immunization with 500 µg peptide or 250 ug protein per host with FCA in 10 SQ sites
1st Booster Day 14 Boost with 250 µg peptide or 125 µg protein per host with FIC in 4 SQ sites
2nd Booster Day 28 Boost with 250 µg peptide or 125 µg protein per host with FIC in 4 SQ sites
Serum Collection (Week 5) Day 35 Bleed ~ 20 ml/rabbit
3rd Booster Day 42 Boost with 250 µg peptide or 125 µg protein per host with FIC in 4 SQ sites
Serum Collection (Week 8)

ELISA
Day 56-62 Bleed ~ 20 ml/rabbit

ELISA assay of control, week 8 collection sera
Final Shipment

Project Completion Verification
Day 63-64 Shipping of control, week 6,8 collection sera

Verify disposition of rabbits, extension or termination
Instruction Due Date Day 72 Termination of animals if instruction not received
Bio-Synthesis offers multiple antigenic peptides (MAPs) as an another method for raising antibodies using synthetic peptides. Peptides are attached through C-terminal to a small non-immunogenic polylysine 4 or 8 branching core. Synthetic peptides build upon these core result in three dimensional molecules with highly localized peptide density, allowing resulting molecular sizes to reach 13-17 kD. MAP system is suitable for direct antibody production without the need to couple to a carrier protein. These high molar ratio and dense packing of multiple copies of the antigenic epitope in a MAP has been shown to produce strong immunogenic response 1-4.

Although MAPs are capable of producing a strong antigenic response to the peptide, there are some drawbacks. Steric hindrance can be an increasing problem with extension of the peptide chain although this can be minimized by having a low loading on the resin. Purification of MAPs by reversed phase HPLC is not normally possible and characterization by mass spectrometry is difficult. Therefore MAPs are usually just dialyzed and the crude product used directly for immunization. Because of these factors, we recommend the conjugation method using a well defined peptide as antigen as the preferred initial option

Characteristics
  1. High molar ratio of peptide antigen to core molecule
  2. Defined chemical structures
  3. Choice of 4-branch, 8 branch, and others
  4. Choice of mono-epitope or di-epitope

MAP Benefits
  1. Does not require the use of a carrier protein to elicit antibody response
  2. Increased coating efficiency on solid surface
  3. Enhanced detection sensitivity for solid phase Immunoassay
  4. Valuable for studies of immunology and vaccine studies

Guidelines
  1. Average peptide length: 10-15 residues
  2. Favored in N-terminal or internal peptide response
  3. Not favored in C-terminal peptide response
  4. Cysteines can cause low yield
  5. Not amenable for further purification.

Links and Resources

Forms:
Order/Quote Page

Additional Phospho-Specific Antibody Information:
Phospho-Specific Life-Cycle Illustration

Sci Apps:
Peptide Property Calculator
Peptide Design Library
Oligo Designer

Please select subject area:
Reference/Citing:
1.
Tam JP, Spetzler JC: Multiple Antigen Peptide System. Methods Enzymol. 1997, 289:612-636.
2.
Tam JP, Zavala F: Multiple antigen peptide: a novel approach to increase detection sensitivity of synthetic peptides in solid-phase immunoassays. J. Immunol. Methods 1989, 124:53-61.
3.
Briand JP, Barin C, Van Regenmortel MH, Muller S: Application and limitations of the multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies. J. Immunol. Methods 1992, 156:255-265.
4.
Schott ME, Wells DT, Schlom J, Abrams SI: Comparison of linear and branched peptide forms (MAPS) in the induction of T helper responses to point-mutated ras immunogens. Cell Immunol. 1996, 174:199-209.
Ordering Services
To place an order or request a quotation, please proceed to our custom Order/Quote page or Contact Us for any other questions.
Order can be placed with either a PO (Purchase Order) or credit card. You may place order online using our secure online ordering system. Our customer service representatives are available 24 hours a day, Monday through Friday, to assist you.
   
We accept POs and major credit cards ( ). Your credit card will be billed under "Bio-Synthesis, Inc." Please complete and return our Business Credit Application. For international orders, we must apply the full charge at the time of the order is placed. In the unlikely event that any given order cannot be filled, our guarantee will take the form of a full refund.